Erasca (NASDAQ: ERAS) insider transactions
In the twelve months to 10 November 2026, executives and directors of Erasca reported 3 open-market sales of 220,000 shares ($2.3m) and 0 open-market purchases, by 2 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 1 April 2026 | Garner Ebun | Chief Legal Officer | Option exercise | +80,000 | $1.70 | 105,076 | Form 4 |
| 1 April 2026 | Garner Ebun | Chief Legal Officer | Open-market sale | −80,000 | $16.40 | 25,076 | Form 4 |
| 4 March 2026 | Morris Shannon | Chief Medical Officer | Option exercise | +20,000 | $1.70 | 20,000 | Form 4 |
| 4 March 2026 | Morris Shannon | Chief Medical Officer | Open-market sale | −20,000 | $15.04 | 0 | Form 4 |
| 7 January 2026 | Garner Ebun | General Counsel & Corp. Sec. | Option exercise | +120,000 | $1.70 | 145,076 | Form 4 |
| 7 January 2026 | Garner Ebun | General Counsel & Corp. Sec. | Open-market sale | −120,000 | $5.59 | 25,076 | Form 4 |
| 15 December 2025 | Chacko David M. | CFO and CBO | Other | +17,793 | $1.19 | 279,980 | Form 4 |
| 15 December 2025 | Garner Ebun | General Counsel & Corp. Sec. | Grant or award | +3,902 | $1.19 | 25,076 | Form 4 |
| 23 May 2025 | Multani Pratik S | Director | Gift | −6,200 | — | 166,666 | Form 4 |
| 23 May 2025 | Multani Pratik S | Director | Gift | +6,200 | — | 6,200 | Form 4 |
| 13 December 2024 | Garner Ebun | General Counsel & Corp. Sec. | Other | +5,731 | $1.56 | 21,174 | Form 4 |
| 13 December 2024 | Chacko David M. | CFO and CBO | Other | +12,324 | $1.56 | 262,187 | Form 4 |
| 14 June 2024 | Garner Ebun | General Counsel & Corp. Sec. | Other | +5,715 | $1.56 | 21,174 | Form 4 |
| 14 June 2024 | Chacko David M. | CFO and CBO | Other | +3,137 | $1.56 | 262,187 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Erasca page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.